PDCD1 and colorectal cancer: In a murine model of colorectal cancer 18F-F-AraG PET was able to successfully predict the response to anti-PD-1 therapy 48 hours after administration of anti-PD-1 therapy, responding mice showed a significantly higher PET signal in their tumors relative to non-responding mice 46.